Insilico Medicine discovers small molecule CDK8 inhibitor to treat cancer
Targeting CDK8/19 may help in enhancing natural killer (NK) cell cytotoxicity and stimulating NK cell-mediated tumour surveillance.
Cerba Research WP
UK’s NICE recommends AstraZeneca’s olaparib to treat cancer types
MHRA fast tracks ADvantage’s immunomodulator for Alzheimer’s disease
Absci and M2GEN partner to expedite cancer drug development
Janssen launches once-daily option for prostate cancer drug Erleada
BioNTech and DualityBio team up to develop ADC therapeutics for cancer
HUTCHMED concludes FDA rolling submission for colorectal cancer treatment
Regeneron and Sonoma Biotherapeutics partner to develop T cell therapies
